NCT03588806View on ClinicalTrials.gov

Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills

PHASE4TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

October 31, 2019

Conditions
Chronic PainOpioid UseDeglutition
Interventions
DRUG

Xtampza ER (oxycodone)

Following baseline assessments, subjects will have their current opioid medication changed to Xtampza ER (oxycodone) for the duration of the study.

Trial Locations (1)

15206

UPMC Pain Medicine at Centre Commons, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

Collegium Pharmaceutical, Inc.

INDUSTRY

lead

Ajay Wasan, MD, Msc

OTHER

NCT03588806 - Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills | Biotech Hunter | Biotech Hunter